Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 61.35
+0.55 (0.90%)
Feb 13, 2026, 4:08 PM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 12.09 billion as of February 13, 2026.
Market Cap
12.09B
Enterprise Value
11.93B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
61.35
Market Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has decreased from 12.97B to 12.09B, a decrease of -6.80%. That is a compound annual growth rate of -11.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 12.09B | 19.22% |
| Dec 31, 2025 | 10.14B | -21.82% |
| Jul 25, 2025 | 12.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 17.53B |
| Keymed Biosciences | 17.40B |
| Zai Lab | 16.67B |
| Everest Medicines | 13.91B |
| Guangzhou Innogen Pharmaceutical Group | 12.62B |
| Shanghai Haohai Biological Technology | 11.04B |
| HBM Holdings | 9.79B |
| Abbisko Cayman | 9.05B |